New Player Joins Search For Effective Huntington's Therapies
LoQus23 Looks To Tackle Neurodegenerative Disease
Despite recent setbacks for Roche and Wave's respective antisense offerings, both those two firms and a number of other companies are trying a variety of approaches to find a treatment for Huntington's.
